Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
1b), with good technical reproducibility and without detrimental batch effects across tandem mass tag (TMT) plexes and specimen sources (Extended Data Fig
Benefits and Risks of Deferiprone in Iron Overload in Thalassaemia and Other Conditions Comparison of Epidemiological and Therapeutic Aspects with Deferoxamine George J Kontoghiorghes Katia Neocleous Annita Kolnagou Deferiprone is the only orally active iron-chelating drug to be used therapeutically in conditions of transfusional iron overload
In addition, a small percentage of patients (7%) experienced skin tingling
1), with the complete dataset available in Supplementary Table 3
US$ 20.37
US$ 22.03
US$ 23.69
US$ 22.95
